LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning ...
LENSAR (NASDAQ:LNSR) just reported results for the second quarter of 2024. LENSAR reported earnings per share of -46 cents. This was below the analyst estimate for EPS of -29 cents. The company ...
ORLANDO, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of ...
Every investor in LENSAR, Inc. (NASDAQ:LNSR) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are retail investors with 40% ownership.